Task Force Overview

From LipidomicsWiki

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
The LipidomicNet consortium consists of six vertical (TFI-VI) and three horizontal integrative (TFVII-TFIX) task forces.<br>Specific enabling technologies and their applications (TF I-IV).<br>Mouse models (TF V).<br>Human clinical trials and ethics issues (TF VI).<br>Translational research (TF VII).<br>LipidomicNet (TF VIII).<br>Dissemination and training (TF IX).<br>  
The LipidomicNet consortium consists of six vertical (TFI-VI) and three horizontal integrative (TFVII-TFIX) task forces.<br>Specific enabling technologies and their applications (TF I-IV).<br>Mouse models (TF V).<br>Human clinical trials and ethics issues (TF VI).<br>Translational research (TF VII).<br>LipidomicNet (TF VIII).<br>Dissemination and training (TF IX).<br>  
 +
 +
 +
<br>
   
   
Line 7: Line 10:
   
   
-
<br>  
+
<br>
 +
<br>
 +
 +
 
 +
<br>
   
   
Line 80: Line 87:
| Karpe
| Karpe
   
   
-
| [[P01 UHREG|P01]], [[P08 UGOT|P08]], [[P09 JUMC|P09]], [[P11 BRC HAS|P11]], [[P12 IEE SAS|P12]], [[P13 BABRAHAM|P13]], [[P14 UH|P14]], [[P15B UBO|P15B]], [[P15A UBO|P15A]], [[P22 UOXF.H7|22]], [[P23 MRC|P23]], and [[P24 JKU|P24]]
+
| [[P01 UHREG|P01]], [[P08 UGOT|P08]], [[P09 JUMC|P09]], [[P11 BRC HAS|P11]], [[P12 IEE SAS|P12]], [[P13 BABRAHAM|P13]], [[P14 UH|P14]], [[P15A UBO|P15A]], [[P15B UBO|P15B]], [[P22 UOXF.H7|22]], [[P23 MRC|P23]], and [[P24 JKU|P24]]
|-
|-
! Horizontal Task Forces
! Horizontal Task Forces

Revision as of 09:14, 23 May 2011

The LipidomicNet consortium consists of six vertical (TFI-VI) and three horizontal integrative (TFVII-TFIX) task forces.
Specific enabling technologies and their applications (TF I-IV).
Mouse models (TF V).
Human clinical trials and ethics issues (TF VI).
Translational research (TF VII).
LipidomicNet (TF VIII).
Dissemination and training (TF IX).




Overview of LipidomicNet Task Forces

The following table shows an overview of the task forces their Leaders and corresponding LipidomicNet partners.






Vertical Task Forces Taskforce chair co-chair Partner(s)
Task Force I Mass-spectrometric and chromatographic methods andpreanalytics for molecular lipid species analyses and stable isotope labelling Prof. Micheal Wakelam PhD. Gerhard Liebisch P01, P02, P04, P06, P07, P11, P13, P14, P15A, P15B, P17, P18, P19, P21, P22, P25
Task Force II Fluorescence-based lipidomic methods on intact cells, labelling lipidomic antibodies and proteins Dr. Christoph Thiele Prof. Dr. Aldona Dembinska-Kiec P01, P04, P09, P11, P13, P14, P15B, P23, P24
Task Force III Affinity binder, ELISA and proteomic mass-spectrometric techniques and reagents Dr. Stefan Müllner Dr. Jens Hansen P01, P07, P16, P20
Task Force IV Gene-, Taqman- and Bead-array reagents and preanalytics (RNA/DNA, Agilent, Affymetrix, Illumina, ABI TLDAs etc) Prof. Dr. Gerd Schmitz Dr. Christian Wolfrum P01, P06, P09
Task Force V Mouse models Dr. Christian Wolfrum Van Dijk P02, P03, P04, P05, P06, and P07
Task Force VI Clinical trials and human ethics Daniela Gasperikova Karpe P01, P08, P09, P11, P12, P13, P14, P15A, P15B, 22, P23, and P24
Horizontal Task Forces



Task Force VII Human/Mouse translational research Prof. Dr. Gerd Schmitz Dr. Isabell Dugail P01, P04, P06, P12, P13, P15A
Task Force VIII LipidomicNet-Bioinformatics Dr. Lennart Martens Prof. Dr. Gerd Schmitz P01, P06, P10, P16, P17, P18, P21, P22, P25
Task Force IX Dissemination, training and communication Prof. Dr. Aldona Dembinska-Kiec Juergen Jonas All partners
Together the specialized vertical and the integrative horizontal Task Forces (TFs) will generate maximal integration and efficient dissemination and training.

Return to Site Map

Personal tools
Create a book